Science Explorer Back to mapMap

Most cited papers from Eiger Biopharmaceuticals (United States)

Eiger Biopharmaceuticals (United States)

What are the most cited papers from Eiger Biopharmaceuticals (United States)?

The most cited paper from Eiger Biopharmaceuticals (United States) is "A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures" (Kenneth H. Dinnon, Sarah R. Leist, Alexandra Schäfer et al., 2020), with 690 citations. Next come "Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial" (241) and "Early Treatment with Pegylated Interferon Lambda for Covid-19" (179).

Showing 50 of 50 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures Kenneth H. Dinnon, Sarah R. Leist, Alexandra Schäfer et al. · Nature Open access 27 Aug 2020 690
2 Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial Jordan J. Feld et al. · The Lancet Respiratory Medicine Open access 7 Feb 2021 241
3 Early Treatment with Pegylated Interferon Lambda for Covid-19 Gilmar Reis et al. · New England Journal of Medicine Open access 8 Feb 2023 179
4 Voreloxin Is an Anticancer Quinolone Derivative that Intercalates DNA and Poisons Topoisomerase II Rachael Elizabeth Hawtin, David E. Stockett, Jo Ann W. Byl et al. · PLoS ONE Open access 15 Apr 2010 150
5 Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial Prasanna K. Jagannathan et al. · Nature Communications Open access 30 Mar 2021 149
6 A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures Kenneth H. Dinnon, Sarah R. Leist, Alexandra Schäfer et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 7 May 2020 90
7 A phase 2 dose‐finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis Cihan Yurdaydın, Onur Keskın, Esra Yurdcu et al. · Hepatology 3 Dec 2021 78
8 PREVENT: A Randomized, Placebo-controlled Crossover Trial of Avexitide for Treatment of Postbariatric Hypoglycemia Colleen M. Craig, Helen Margaret Lawler, Clare Jung Eun Lee et al. · The Journal of Clinical Endocrinology & Metabolism Open access 22 Feb 2021 68
9 Using Chimeric Mice with Humanized Livers to Predict Human Drug Metabolism and a Drug-Drug Interaction Toshihiko Nishimura, Yajing Hu, Manhong Wu et al. · Journal of Pharmacology and Experimental Therapeutics Open access 9 Nov 2012 61
10 Illusions of safety: antimutagens can be mutagens, and anticarcinogens can be carcinogens Errol Zeiger · Mutation Research/Reviews in Mutation Research 30 Jan 2003 56
11 Investigation of the Low-Dose Response in the In Vivo Induction of Micronuclei and Adducts by Acrylamide Errol Zeiger, Leslie Recio, Timothy R. Fennell et al. · Toxicological Sciences Open access 17 Oct 2008 54
12 Treatment of chronic hepatitis D with peginterferon lambda—the phase 2 LIMT-1 clinical trial Ohad Etzion, Saeed Sadiq Hamid, Yoav Lurie et al. · Hepatology Open access 17 Feb 2023 46
13 Beware of the black swan: The limitations of risk analysis for predicting the extreme impact of rare process safety incidents John F. Murphy, J. T. Conner · Process Safety Progress 5 Oct 2012 43
14 History and rationale of genetic toxicity testing: An impersonal, and sometimes personal, view Errol Zeiger · Environmental and Molecular Mutagenesis 2004 43
15 Historical perspective on the development of the genetic toxicity test battery in the United States Errol Zeiger · Environmental and Molecular Mutagenesis 25 Aug 2010 39
16 Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9‐39) for treatment of post‐bariatric hypoglycaemia Marilyn J. Tan, Cynthia A Lamendola, Roger Luong et al. · Diabetes Obesity and Metabolism 6 Apr 2020 36
17 Hypoxic tolerance enhanced by beta-hydroxybutyrate-glucagon in the mouse. Steven M. Eiger, Jeffrey R. Kirsch, Louis G. D’Alecy · Stroke Sep 1980 35
18 The Political Future of Social Medicine: Reflections on Physicians as Activists Hartmut Geiger · Academic Medicine 4 Jan 2017 30
19 Black swans, white swans, and 50 shades of grey: Remembering the lessons learned from catastrophic process safety incidents John F. Murphy, James Conner · Process Safety Progress 6 Nov 2013 26
20 The COVID‐19 pandemic: Is it a “Black Swan”? Some risk management challenges in common with chemical process safety John F. Murphy, J. Andrew Jones, James Conner · Process Safety Progress Open access 27 Apr 2020 23
21 A Comparison of the Representation of Women in Editor Positions at Major Medical Journals in 2021 vs 2011 Christina Starchl, Vianca Shah, Ines Zollner‐Schwetz et al. · Academic Medicine Open access 6 Sep 2022 20
22 An illusion of hormesis in the Ames test: Statistical significance is not equivalent to biological significance Errol Zeiger, George R Hoffmann · Mutation Research/Genetic Toxicology and Environmental Mutagenesis 29 Mar 2012 15
23 Multicriteria Optimization William R. Spillers, Keith M. MacBain · Structural Optimization Book chapter 2009 9
24 Peginterferon-lambda for the treatment of COVID-19 in outpatients Jordan J. Feld et al. · medRxiv PreprintOpen access 12 Nov 2020 9
25 A new dual-targeting real-time RT-PCR assay for hepatitis D virus RNA detection Yan Wang, Jeffrey S. Glenn, Mark A. Winters et al. · Diagnostic Microbiology and Infectious Disease 29 May 2018 9
26 Treatment of Angular Deformity and Limb Length Discrepancy With a Retrograde Femur Magnetic Intramedullary Nail: A Fixator-assisted, Blocking Screw Technique Erik J. Geiger, Adam Daniel Geffner, S. Robert Rozbruch et al. · JAAOS Global Research and Reviews Open access May 2023 8
27 Rebuilding Nursing Culture Through Application of Social Identity Theory and Inclusivity in Health Care Systems Noreen Bernard, Robin A. Geiger · Nursing Administration Quarterly 29 Mar 2024 7
28 Components, Implementation, and Outcomes of a Nursing Professional Practice Model Wendy Hamilton, Mariyam Javed, Judy Orina et al. · Nursing Administration Quarterly 5 Dec 2022 6
29 Lack of Access to Treatment as a Barrier to HCV Screening Brigg A. Reilley, Jessica D. Leston, John Terrell Redd et al. · Journal of Public Health Management and Practice 29 Aug 2013 6
30 Communication and Education Skills B B Holli, R J Calabrese · Topics in Clinical Nutrition 1988 4
31 Optimality Criteria Methods William R. Spillers, Keith M. MacBain · Structural Optimization Book chapter 2009 3
32 Penelitian Public Relation Eiger Adventure Rio Aria Seta · Jurnal Public Relations (J-PR) Open access 17 Nov 2022 2
33 Prévalence des attitudes et comportements inadaptés face à l’alimentation chez des adolescentes de la région de Montréal Daniel Bolduc, Howard P. Steiger, Freedom Y. K. Leung · Santé mentale au Québec Open access 11 Sep 2007 2
34 Introduction William R. Spillers, Keith M. MacBain · Structural Optimization Book chapter 2009 1
35 The Value of the Patient-Centered Medical Home in Getting Adults Suffering From Acute Conditions Back to Work Tanekkia M Taylor-Clark, Pauline A. Swiger, Larry R. Hearld et al. · Journal of Ambulatory Care Management 20 Oct 2021 1
36 Sequential Linear Programming and the Incremental Equations of Structures William R. Spillers, Keith M. MacBain · Structural Optimization Book chapter 2009 1
37 Dose-dependent decrease in hepatitis delta virus (HDV) RNA achieved with the oral prenylation inhibitor lonafarnib in a proof-of-concept, randomised, double-blinded, placebo-controlled study in patients with chronic HDV infection Choong Hou Koh, Laëtitia Canini, Harel Dahari et al. · Journal of Clinical Virology 21 Jul 2015 1
38 Structural optimization using incremental equations and sequential linear programming Keith M. MacBain, William R. Spillers · Structural and Multidisciplinary Optimization 11 Aug 2006 1
39 Simple bar graph displays for control variables and alarm status Sulaiman Hussaini Conference paper 1994 1
40 Some Basic Optimization Problems William R. Spillers, Keith M. MacBain · Structural Optimization Book chapter 2009 1
41 Crumbling bridges: The failed economics of software maintenance Jc Herz · Cyber security. 28 Oct 2024 0
42 Operational Planning and Design Issues for Retractable Membrane Roofs David J. Campbell Conference paperOpen access 2023 0
43 P016: Results of an open-label, single-center, clinical study evaluating the safety and tolerability of pentosan polysulfate sodium in mucopolysaccharidosis I subjects Curtis Gravance, Drago Bratkovic, David Ketteridge et al. · Genetics in Medicine Open Open access 2023 0
44 Strong correlation between HBsAg, ALT and HDV-RNA levels in patients with chronic hepatitis D. Results of phase 3 D-LIVR study. Marı́a Buti, Ohad Etzion, Adriana Palom et al. · Journal of Hepatology Jul 2022 0
45 THE GROWTH OF SINGLE CRYSTAL AND THE DETERMINATION OF CRYSTALLOGRAPHIC PA RAMETERS OF (L-TRYPTOPHAN)~(A1)-INSULIN AND (D-TRYPTOPHAN)~(A1)-INSULIN D Iang, Lf G 1985 0
46 OR20-5 28-Day Dosing with Avexitide Improves Hyperinsulinemic Hypoglycemia in Patients with Severe, Refractory Post-Bariatric Hypoglycemia: The PREVENT Study Clare J. Lee, Helen Margaret Lawler, Marilyn J. Tan et al. · Journal of the Endocrine Society Open access Apr 2019 0
47 Trauma Systems Development Juliet Geiger, Jolene R. Whitney · Journal of Trauma Nursing Jul 2010 0
48 Practical Matters: The Work of Farkas and Jarmai William R. Spillers, Keith M. MacBain · Structural Optimization Book chapter 2009 0
49 Beams and Plates: The Work of Rozvany William R. Spillers, Keith M. MacBain · Structural Optimization Book chapter 2009 0
50 Some Tools of Optimization William R. Spillers, Keith M. MacBain · Structural Optimization Book chapter 2009 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.